Recent studies have revealed a vital role for KLF15 as an effective therapeutic target for the treatment of cardiovascular diseases due to its effects on transcriptional factors such as myocyte enhancer factor 2 (MEF2), GATA-binding protein 4 (GATA4), and myocardin 42. This evidence concerns the gene GATA4 and cardiovascular disorder.